4.8 Editorial Material

To Infinium, and Beyond!

期刊

CANCER CELL
卷 17, 期 5, 页码 419-420

出版社

CELL PRESS
DOI: 10.1016/j.ccr.2010.04.020

关键词

-

资金

  1. NCI NIH HHS [R01 CA129541, R01 CA129541-04] Funding Source: Medline

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Clinical Neurology

cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors

David W. Ellison, Kenneth D. Aldape, David Capper, Maryam Fouladi, Mark R. Gilbert, Richard J. Gilbertson, Cynthia Hawkins, Thomas Merchant, Kristian Pajtler, Sriram Venneti, David N. Louis

BRAIN PATHOLOGY (2020)

Article Cell Biology

DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma

Deanna M. Patmore, Amir Jassim, Erica Nathan, Reuben J. Gilbertson, Daniel Tahan, Nadin Hoffmann, Yiai Tong, Kyle S. Smith, Thirumala-Devi Kanneganti, Hiromichi Suzuki, Michael D. Taylor, Paul Northcott, Richard J. Gilbertson

DEVELOPMENTAL CELL (2020)

Article Cell Biology

Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis

Frank Szulzewsky, Sonali Arora, Pia Hoellerbauer, Claire King, Erica Nathan, Marina Chan, Patrick J. Cimino, Tatsuya Ozawa, Daisuke Kawauchi, Kristian W. Pajtler, Richard J. Gilbertson, Patrick J. Paddison, Valeri Vasioukhin, Taranjit S. Gujral, Eric C. Holland

GENES & DEVELOPMENT (2020)

Review Developmental Biology

Harnessing brain development to understand brain tumours

Silvia Marino, Richard J. Gilbertson

Summary: Brain tumors are the most common solid neoplasms in children, representing one quarter of all childhood cancers. Understanding basic developmental mechanisms has greatly contributed to our knowledge of the pathogenesis of these tumors, influencing clinical decisions in treating children with these diseases.

DEVELOPMENT (2021)

Article Oncology

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

Amar Gajjar, Giles W. Robinson, Kyle S. Smith, Tong Lin, Thomas E. Merchant, Murali Chintagumpala, Anita Mahajan, Jack Su, Eric Bouffet, Ute Bartels, Tal Schechter, Tim Hassall, Thomas Robertson, Wayne Nicholls, Sridharan Gururangan, Kristin Schroeder, Michael Sullivan, Greg Wheeler, Jordan R. Hansford, Stewart J. Kellie, Geoffrey McCowage, Richard Cohn, Michael J. Fisher, Matthew J. Krasin, Clinton F. Stewart, Alberto Broniscer, Ivo Buchhalter, Ruth G. Tatevossian, Brent A. Orr, Geoff Neale, Paul Klimo, Frederick Boop, Ashok Srinivasan, Stefan M. Pfister, Richard J. Gilbertson, Arzu Onar-Thomas, David W. Ellison, Paul A. Northcott

Summary: The study identified new risk stratification for medulloblastoma treatment through molecular classification and risk factor analysis, finding differences in PFS among patients with different genotypes and subtypes.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Editorial Material Oncology

Maturation Block in Childhood Cancer

Sam Behjati, Richard J. Gilbertson, Stefan M. Pfister

Summary: The main differences between childhood tumors and adult cancers lie in the cellular origin and development stages, which may offer insights for researching and treating childhood cancer.

CANCER DISCOVERY (2021)

Article Oncology

ZFTA Translocations Constitute Ependymoma Chromatin Remodeling and Transcription Factors

Robert Kupp, Lisa Ruff, Sabrina Terranova, Erica Nathan, Stephane Ballereau, Rory Stark, Chandra Sekhar Reddy Chilamakuri, Nadin Hoffmann, Katherine Wickham-Rahrmann, Marcus Widdess, Amir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, Tuyu Zheng, Mohankumar Murugesan, Stefan M. Pfister, Daisuke Kawauch, Kristian W. Pajtler, Benjamin Deneen, Stephen C. Mack, Katherine E. Masih, Berkley E. Gryder, Javed Khan, Richard J. Gilbertson

Summary: The study reveals that ZFTA fusion proteins drive the development of supratentorial ependymoma and unravels their transformation mechanism, providing clues for therapy. By investigating deletion-mutant genes, the study identifies a tripartite transformation mechanism of ZFTA-containing fusions, including nuclear translocation, chromatin binding, and recruitment of chromatin modifier complexes.

CANCER DISCOVERY (2021)

Article Oncology

Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas

Tuyu Zheng, David R. Ghasemi, Konstantin Okonechnikov, Andrey Korshunov, Martin Sill, Kendra K. Maass, Patricia Benites Goncalves da Silva, Marina Ryzhova, Johannes Gojo, Damian Stichel, Amir Arabzade, Robert Kupp, Julia Benzel, Shinichiro Taya, Toma Adachi, Ryo Shiraishi, Nicolas U. Gerber, Dominik Sturm, Jonas Ecker, Philipp Sievers, Florian Selt, Rebecca Chapman, Christine Haberler, Dominique Figarella-Branger, Guido Reifenberger, Gudrun Fleischhack, Stefan Rutkowski, Andrew M. Donson, Vijay Ramaswamy, David Capper, David W. Ellison, Christel C. Herold-Mende, Ulrich Schueller, Sebastian Brandner, Pablo Hernaiz Driever, Johan M. Kros, Matija Snuderl, Till Milde, Richard G. Grundy, Mikio Hoshino, Stephen C. Mack, Richard J. Gilbertson, David T. W. Jones, Marcel Kool, Andreas von Deimling, Stefan M. Pfister, Felix Sahm, Daisuke Kawauchi, Kristian W. Pajtler

Summary: Supratentorial ependymomas can be categorized into tumors with ZFTA-RELA or YAP1 fusions, fusion-negative subependymomas, and other tumors that cannot be classified. ZFTA acts as a partner gene in oncogenic fusions with various histologic features, with GLI2 identified as a key regulator of tumorigenesis in these tumors. Targeting GLI2 with arsenic trioxide shows potential therapeutic benefits for ZFTA fusion-positive tumors.

CANCER DISCOVERY (2021)

Article Oncology

ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma

Amir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, Hsiao-Chi Chen, Selin Jessa, Bryan Rivas, Austin J. Stuckert, Minerva Solis, Alisha Kardian, Dana Tlais, Brian J. Golbourn, Ann-Catherine J. Stanton, Yuen San Chan, Calla Olson, Kristen L. Karlin, Kathleen Kong, Robert Kupp, Baoli Hu, Sarah G. Injac, Madeline Ngo, Peter R. Wang, Luz A. De Leon, Felix Sahm, Daisuke Kawauchi, Stefan M. Pfister, Charles Y. Lin, H. Courtney Hodges, Irtisha Singh, Thomas F. Westbrook, Murali M. Chintagumpala, Susan M. Blaney, Donald W. Parsons, Kristian W. Pajtler, Sameer Agnihotri, Richard J. Gilbertson, Joanna Yi, Nada Jabado, Claudia L. Kleinman, Kelsey C. Bertrand, Benjamin Deneen, Stephen C. Mack

Summary: The study reveals the critical role of ZR(fus) in supratentorial ependymomas by activating the NF kappa B pathway and recruiting transcriptional coactivators to promote gene expression. Its target genes are often involved in developmental programs and tumor networks, providing insights for potential therapeutic strategies.

CANCER DISCOVERY (2021)

Article Oncology

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

Anthony P. Y. Liu, Kyle S. Smith, Rahul Kumar, Leena Paul, Laure Bihannic, Tong Lin, Kendra K. Maass, Kristian W. Pajtler, Murali Chintagumpala, Jack M. Su, Eric Bouffet, Michael J. Fisher, Sridharan Gururangan, Richard Cohn, Tim Hassall, Jordan R. Hansford, Paul Klimo, Frederick A. Boop, Clinton F. Stewart, Julie H. Harreld, Thomas E. Merchant, Ruth G. Tatevossian, Geoffrey Neale, Matthew Lear, Jeffery M. Klco, Brent A. Orr, David W. Ellison, Richard J. Gilbertson, Arzu Onar-Thomas, Amar Gajjar, Giles W. Robinson, Paul A. Northcott

Summary: The study demonstrates the clinical utility of CSF-derived cell-free DNA (cfDNA) as a biomarker of measurable residual disease (MRD) in children with medulloblastoma. Detection of MRD, particularly in patients with persistent MRD, is associated with a higher risk of disease progression. Early detection of MRD using liquid biopsies may aid in monitoring disease progression and treatment efficacy in medulloblastoma patients.

CANCER CELL (2021)

Article Cell Biology

Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas

Pooja Panwalkar, Benita Tamrazi, Derek Dang, Chan Chung, Stefan Sweha, Siva Kumar Natarajan, Matthew Pun, Jill Bayliss, Martin P. Ogrodzinski, Drew Pratt, Brendan Mullan, Debra Hawes, Fusheng Yang, Chao Lu, Benjamin R. Sabari, Abhinav Achreja, Jin Heon, Olamide Animasahun, Marcin Cieslik, Christopher Dunham, Stephen Yip, Juliette Hukin, Joanna J. Phillips, Miriam Bornhorst, Andrea M. Griesinger, Andrew M. Donson, Nicholas K. Foreman, Hugh J. L. Garton, Jason Heth, Karin Muraszko, Javad Nazarian, Carl Koschmann, Li Jiang, Mariella G. Filbin, Deepak Nagrath, Marcel Kool, Andrey Korshunov, Stefan M. Pfister, Richard J. Gilbertson, C. David Allis, Arul M. Chinnaiyan, Sophia Y. Lunt, Stefan Bluml, Alexander R. Judkins, Sriram Venneti

Summary: Childhood posterior fossa group A ependymomas (PFAs) have limited treatment options and poor prognoses compared to group B ependymomas (PFBs). PFAs exhibit enhanced glycolysis and tricarboxylic acid (TCA) cycle metabolism, with high expression of glycolytic genes associated with a poor outcome. These tumors also show high EZHIP expression linked to a dismal prognosis and elevated activating mark histone H3 lysine 27 acetylation (H3K27ac). Repurposing the antidiabetic drug metformin has shown therapeutic efficacy in vitro and in vivo in patient-derived PFA xenografts by targeting integrated metabolic/epigenetic pathways.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Genetics & Heredity

The NALCN channel regulates metastasis and nonmalignant cell dissemination

Eric P. Rahrmann, David Shorthouse, Amir Jassim, Linda P. Hu, Mariaestela Ortiz, Betania Mahler-Araujo, Peter Vogel, Marta Paez-Ribes, Atefeh Fatemi, Gregory J. Hannon, Radhika Iyer, Jay A. Blundon, Filipe C. Lourenco, Jonathan Kay, Rosalynn M. Nazarian, Benjamin A. Hall, Stanislav S. Zakharenko, Douglas J. Winton, Liqin Zhu, Richard J. Gilbertson

Summary: The ion channel NALCN has been identified as a key regulator of cancer metastasis and nonmalignant cell dissemination, even in the absence of oncogenic mutations, allowing normal structures to form at secondary sites. This finding uncovers a potential new target for antimetastatic therapies.

NATURE GENETICS (2022)

Article Multidisciplinary Sciences

Human fetal cerebellar cell atlas informs medulloblastoma origin and oncogenesis

Zaili Luo, Mingyang Xia, Wei Shi, Chuntao Zhao, Jiajia Wang, Dazhuan Xin, Xinran Dong, Yu Xiong, Feng Zhang, Kalen Berry, Sean Ogurek, Xuezhao Liu, Rohit Rao, Rui Xing, Lai Man Natalie Wu, Siying Cui, Lingli Xu, Yifeng Lin, Wenkun Ma, Shuaiwei Tian, Qi Xie, Li Zhang, Mei Xin, Xiaotao Wang, Feng Yue, Haizi Zheng, Yaping Liu, Charles B. Stevenson, Peter de Blank, John P. Perentesis, Richard J. Gilbertson, Hao Li, Jie Ma, Wenhao Zhou, Michael D. Taylor, Q. Richard Lu

Summary: In this study, single-cell profiling of human fetal cerebella was performed to investigate the cellular states and regulatory networks in medulloblastomas (MBs). The researchers found a unique transitional cerebellar progenitor population enriched in aggressive MB subgroups and identified transcriptional determinants HNRNPH1 and SOX11 that are correlated with prognosis in group 3 MBs. Genomic analysis revealed long-range chromatin loops connecting HNRNPH1/SOX11-targeted super-enhancers to regulatory elements of the oncogenic driver MYC in group 3 MBs. Targeting the transitional progenitor regulators inhibited MYC expression and MB growth. This study provides new insights into the cellular and molecular characteristics of MBs, which may have implications for disease prognosis and potential therapeutic strategies.

NATURE (2022)

Review Oncology

Cancers make their own luck: theories of cancer origins

Amir Jassim, Eric P. Rahrmann, Ben D. Simons, Richard J. Gilbertson

Summary: Understanding the combination of cell intrinsic and extrinsic factors in initiating transformation is important for cancer prevention, detection, and early treatment. This review outlines current theories on cancer origins and the underlying determinants of cancer risk. While cancer has been a leading cause of death for decades, controversy remains regarding the transformation of tissues, hindering effective prevention and early intervention. By understanding the complex interplay of cell intrinsic and extrinsic factors, effective strategies for preventing, detecting, and stopping cancer before it becomes incurable can be discovered.

NATURE REVIEWS CANCER (2023)

Article Biochemistry & Molecular Biology

SMAD4 and KCNQ3 alterations are associated with lymph node metastases in oesophageal adenocarcinoma

Kieran Foley, David Shorthouse, Eric Rahrmann, Lizhe Zhuang, Ginny Devonshire, Rebecca C. OCCAMS Consortium, Rebecca C. Fitzgerald, Benjamin A. Hall

Summary: Metastasis in oesophageal adenocarcinoma (OAC) is a crucial factor affecting survival. Radiological staging is commonly used to assess metastases, but its accuracy is limited. This study analyzed lymph node metastases and identified new roles of genes SMAD4 and KCNQ3 in metastasis. The findings suggest that both genes could serve as novel biomarkers for metastatic risk and offer potential new targets for drug treatment.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2024)

暂无数据